Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05286034

Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme

Artificial Intelligence-assisted Decision-making to Improve Women's Participation to Cervical Cancer Screening in Occitanie Region-France

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
3,000 (estimated)
Sponsor
International Agency for Research on Cancer · Academic / Other
Sex
Female
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

This project looks to improve the return rate of HPV self-sampling (HPVss) as well as the management of women HPVss positive.

Detailed description

France has already implemented a cervical screening programme based on HPV test for the whole female population aged 30-65 years. Non-participant women can perform HPV test at their home. However, less than 20% of French women performed vaginal self-sampling when a kit was sent to their home. Women with lower income and educational levels participate less to cervical screening. A variety of personal, practitioner, test-related and logistical barriers negatively impact the screening participation of French women. Key barriers to participation could be addressed by overcoming disparities in HPV-related knowledge and perceptions about cervical cancer screening. This study aims to evaluate the impact of sending HPV self-sampling kit at women's home, associated with providing, through multiple mobile channels, a multi-language decision aid designed for women with lower education accessible via artificial intelligence-based ChatBot. This decision aid will help women review high quality evidence on cervical cancer disease and screening modalities.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDecision aid tailored to women with lower educational attainment,accessible via artificial intelligence-based Chatbot platformsNon-compliant women those that have not been screened for more than 4 years and living in the disadvantaged areas will be sent screening reminder letters to perform HPV self-sampling (HPVss) test, with access to decision aid tailored to women with lower education attainment and available via Chatbot platforms. ChatBot will deliver information in a responsive, conversational way via text and spoken language in multiple languages through multiple mobile channels.

Timeline

Start date
2025-11-03
Primary completion
2026-07-31
Completion
2026-08-18
First posted
2022-03-18
Last updated
2026-03-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05286034. Inclusion in this directory is not an endorsement.